HIGHLIGHTS
- who: Angelika J. Fischbeck from the Immunoanalytics, Helmholtz Center Munich, Munich, Germany, Medizinische Klinik und Poliklinik IV, Ludwig-MaximiliansUniversity Munich, Munich, Germany, Department of Biology II, Ludwig-Maximilians-University Munich, Martinsried have published the research: Tumor Lactic Acidosis: Protecting Tumor by Inhibiting Cytotoxic Activity Through Motility Arrest and Bioenergetic Silencing, in the Journal: (JOURNAL)
SUMMARY
Immunotherapies, foremost immune checkpoint blockade (ICB) and adoptive T_cell therapy (ACT), have changed the landscape of cancer treatment by producing long-lasting and durable responses in a number of patients, even in those where all available treatment options . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.